INVABlog

Direct oral anticoagulants (DOACs) have revolutionized the management of deep vein thrombosis (DVT) and other thromboembolic disorders over the past decade. These agents offer significant

Coronary artery disease (CAD) remains the leading cause of mortality worldwide, responsible for approximately one-third of all deaths in individuals over age 35. This complex

Upper extremity deep vein thrombosis (UEDVT) represents approximately 10% of all deep vein thrombosis cases but is increasingly recognized as a significant clinical entity with

Secondary prevention represents a critical component in the management of patients with established coronary artery disease, encompassing a comprehensive set of interventions aimed at reducing

Thrombophilia, a predisposition to thrombosis due to abnormalities in the coagulation system, represents an important consideration in the evaluation and management of patients with deep

Percutaneous coronary intervention (PCI) has revolutionized the treatment of coronary artery disease since its introduction over four decades ago, evolving from simple balloon angioplasty to

Coronary stents have revolutionized the treatment of coronary artery disease since their introduction in the 1980s, evolving from simple metallic scaffolds to sophisticated drug-delivery platforms

Coronary chronic total occlusions (CTOs) represent one of the most challenging scenarios in interventional cardiology, defined as complete coronary artery blockages with TIMI 0 flow

Fractional Flow Reserve (FFR) has revolutionized the assessment of coronary artery disease by providing a physiological measure of lesion significance beyond traditional anatomical evaluation. This

Intravascular imaging has transformed the assessment and management of coronary artery disease by providing detailed visualization of vessel wall and lumen beyond what conventional angiography